Dear Lead Zirger, The American Pharmacists Association (APhA) appreciates the opportunity to provide CDC and the Department of Health and Human Services (HHS) with comments on the "mChoice: Improving PrEP Uptake and Adherence among Minority MSM through Tailored Provider Training and Adherence Assistance in Two High Priority Settings" project. APhA represents pharmacists, student pharmacists, and pharmacy technicians in all practice settings, including but not limited to community pharmacies, hospitals, long-term care facilities, specialty pharmacies, community health centers, physician offices, ambulatory clinics, managed care organizations, hospice settings, and government facilities. Our members strive to improve medication use, advance patient care, and enhance public health. Full comments are attached.
CDCNonrulemakingCDC-2026-1189
mChoice: Improving PrEP Uptake and Adherence among Minority MSM through Tailored Provider Training and Adherence Assistance in Two High Priority Settings
RIN
—
Last modified
Sep 8, 2026
Comment window
closed 13d ago
American Pharmacists Association (APhA) filings
1
Activity
American Pharmacists Association (APhA) filed 1 comment on this docket between Sep 8, 2026 and Sep 8, 2026. 0 other organizations filed here. The comment window closed 13d ago.
What American Pharmacists Association (APhA) filed (1)
Sep 8, 2026· Comment from American Pharmacists Association· CDC-2026-1189-0002
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (0)
See everyone who commented →- American Pharmacists Association (APhA)THIS ORG1 filing · confidence 97%